Compare ABOS & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABOS | MFM |
|---|---|---|
| Founded | 1996 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.9M | 224.5M |
| IPO Year | 2021 | N/A |
| Metric | ABOS | MFM |
|---|---|---|
| Price | $2.15 | $5.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 620.2K | 231.9K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $181.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.19 | $5.03 |
| 52 Week High | $3.60 | $5.67 |
| Indicator | ABOS | MFM |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 31.81 |
| Support Level | $2.13 | $5.35 |
| Resistance Level | $2.43 | $5.47 |
| Average True Range (ATR) | 0.16 | 0.04 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 6.12 | 8.33 |
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.